0.6971

7.93% 0.0512

After Hours: .67 -0.0271 -3.89%

Hoth Therapeutics Inc (HOTH)

Overview News Price History Financials Discussions Forecast Stock Split

Hoth Therapeutics Inc stock is traded at $0.6971, with a volume of 7.45M. It is up +7.93% in the last 24 hours and down -32.32% over the past month. Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

Previous Close:

$0.6459

Open:

$0.6227

24h Volume:

7.45M

Relative Volume:

3.52

Market Cap:

$13.33M

Revenue:

Net Income/Loss:

$-12.47M

P/E Ratio:

-0.7651

EPS:

-0.9111

Net Cash Flow:

$-10.10M

1W Performance:

+23.97%

1M Performance:

-32.32%

6M Performance:

-54.44%

1Y Performance:

-13.55%

1-Day Range:

$0.583

$0.722

1-Week Range:

$0.4894

$0.7816

52-Week Range:

$0.4894

$2.115

Hoth Therapeutics Inc Stock (HOTH) Company Profile

Name

Hoth Therapeutics Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

(646)756-2997

Address

1177 AVENUE OF THE AMERICAS, NEW YORK, NY

Employee

Twitter

Next Earnings Date

2026-03-27

Latest SEC Filings

HOTH's Discussions on Twitter

Compare HOTH vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HOTH Hoth Therapeutics Inc	0.6971	12.35M	0	-12.47M	-10.10M	-0.9111
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-15-19	Initiated	The Benchmark Company	Speculative Buy

Hoth Therapeutics Inc Stock (HOTH) Latest News

Apr 14, 2026

Hoth Therapeutics Reports Positive HT VA Study Data Highlighting GDNF Driven Metabolic Reprogramming In Fatty Liver Disease - BioPharma APAC

Apr 14, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 14, 2026

Emerging Now: ANY, GPRO, HOTH, SNAL Shift Strategic Focus in 2026 - Barchart

Apr 14, 2026

12 Health Care Stocks Moving In Tuesday's Intraday SessionAdagio Medical Holdings (NASDAQ:ADGM), Allog - Benzinga

Apr 14, 2026

Move Over Novo NordiskThis Small Company Study Flags Edge In Fatty Liver Drug - Benzinga

Apr 14, 2026

Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide - Yahoo Finance

Apr 14, 2026

Trending Stocks Today | Perfect Moment Surges 88.88% Pre-Market - Moomoo

Apr 14, 2026

Hoth Therapeutics Reports Positive GDNF Data for Fatty Liver Disease - National Today

Apr 14, 2026

Apr 13, 2026

Why Is HOTH Stock Up 70% After-Hours Today? - Stocktwits

Apr 13, 2026

Hoth Therapeutics (Hoth) Reports Positive Ht-Va Crada Data Gdnf Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene And Activates Fat-Burning Pathways, Outperforming Semaglutide - TradingView — Track All Markets

Apr 13, 2026

Hoth Therapeutics announces issuance of Chinese patent for cancer cell-targeting technology - SelectScience

Apr 13, 2026

HOTH.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 13, 2026

Apr 11, 2026

Aug Update: Is Hoth Therapeutics Inc benefiting from innovation trends2026 Decliners & High Accuracy Investment Entry Signals - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

HOTH.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 10, 2026

Apr 08, 2026

Trend Report: Is Hoth Therapeutics Inc stock trending bullish2026 Institutional Moves & High Win Rate Trade Tips - baoquankhu1.vn

Apr 08, 2026

HOTH.O PE Ratio & Valuation, Is HOTH.O Overvalued - Intellectia AI

Apr 08, 2026

HOTH.O Forecast — Price Prediction for 2026. Should I Buy HOTH.O? - Intellectia AI

Apr 08, 2026

Apr 07, 2026

Exclusive: Hoth Therapeutics targets faster drug discovery with new AI platform - MSN

Apr 07, 2026

HOTH.O - Reuters

Apr 07, 2026

Apr 05, 2026

Guidance Update: Whats the fair value of Hoth Therapeutics Inc stock2026 Earnings Surprises & Stock Timing and Entry Methods - baoquankhu1.vn

Apr 05, 2026

Apr 03, 2026

Hoth Therapeutics Completes Registered Direct Offering Financing - The Globe and Mail

Apr 03, 2026